Case Report
BibTex RIS Cite

Unusual surgical treatment option for an uncommon disease: Ureterocutaneostomy in an emphysemateous pyelonephritis patient.

Year 2023, Volume: 17 Issue: 3, 253 - 255, 29.05.2023
https://doi.org/10.12956/tchd.1198673

Abstract

Emphysematous pyelonephritis (EPN) is severe necrotising inflammation of renal parenchyma. Because of the devastating consequences of the pathology aggressive treatment can prevent permanent renal damage. Fifteen-year-old-girl patient without medical follow-up applied to emergency room with fever and vomiting. Computed Tomography (CT) revealed EPN. After diagnostic procedure minimal invasive procedures like double J catheter and nephrostomy tube insertion failed. While taking into account family’s treatment and medical follow-up compliance, also severe dilatation in both ureters made bilateral ureterocutaneostomy (UC) to be considered as a feasible option. UC creation can be thought as a safe and effective alternative surgical procedure. Pediatric neurogenic bladder (NB) population incompatible to treatment and follow-up are candidates for EPN development. We also believe that UC can be beneficial in terms of acute and long-term management of EPN in NB patients who the clinician thinks will not be compatible with complex surgical intervention, follow-up and treatment.

References

  • REFERENCES
  • 1-Kitano H, Hieda K, Kitagawa H, Nakaoka Y, Koba Y, Ota K et al. Case Report: Emphysematous Pyelonephritis With a Congenital Giant Ureterocele. Front Pediatr. 2021;9:775468.
  • 2-Kelly HA, MacCallum WG. Pneumaturia. JAMA. (1898) XXXI:375–81.
  • 3- Pode D, Perlberg S, Fine H. Emphysematous renal and perirenal infection in nondiabetic patient. Urology. 1985;26(3):313-5.
  • 4- Arsene C, Saste A, Arul S, Mestrovich J, Kammo R, Elbashir M et al. A case series of emphysematous pyelonephritis. Case Rep Med. 2014;2014:587926.
  • 5- Lu YC, Chiang BJ, Pong YH, Chen CH, Pu YS, Hsueh PR et al. Emphysematous pyelonephritis: clinical characteristics and prognostic factors. Int J Urol. 2014 Mar;21:277-82.
  • 6- Jiya FB, Ibitoye PK, Jiya NM, Amodu-Sanni M, Mohammed Y, Aquib DM et al. Emphysematous pyelonephritis in an infant from Sokoto, north-western Nigeria. Afr J Lab Med. 2021;10:1181.
  • 7- Roberts JA. Management of pyelonephritis and upper urinary tract infections. Urol Clin North Am. 1999;26(4):753-63.
  • 8- Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160(6):797-805.
  • 9- Mohsin N, Budruddin M, Lala S, Al-Taie S. Emphysematous pyelonephritis: a case report series of four patients with review of literature. Ren Fail. 2009;31(7):597-601.
  • 10- Turney JH. Renal conservation for gas-forming infections. Lancet. 2000;355(9206):770-1.

Nadir Bir Hastalık için Olağandışı Cerrahi Tedavi Seçeneği: Amfizematöz Piyelonefritli hastada Üreterokutanostomi

Year 2023, Volume: 17 Issue: 3, 253 - 255, 29.05.2023
https://doi.org/10.12956/tchd.1198673

Abstract

Amfizematöz piyelonefrit (AP), renal parankimin ileri derece nekrotizan inflamasyonudur. Patolojinin yıkıcı sonuçları nedeniyle agresif tedavi kalıcı böbrek hasarını önleyebilir. On beş yaşında takipsiz kız hasta acil servise ateş ve kusma şikayeti ile başvurdu. Bilgisayarlı Tomografi (BT) AP şeklinde rapor edildi. Tanı sürecinden sonra bilateral double J kateter veya nefrostomi gibi minimal invaziv girişimler başarısız oldu. Hastanın postür bozukluğu nedeniyle nefrostomi tüpü ile drenaj yapılamadı. Ailenin tedavisi ve tıbbi takip uyumu dikkate alınarak, her iki üreterde de ciddi dilate olması bilateral üreterokütanostominin (ÜK) uygun bir seçenek olarak düşünülmesine neden oldu. ÜK oluşturulması güvenli ve etkili alternatif bir cerrahi prosedür olarak düşünülebilir. Tedavi ve takibe uyumsuz pediatrik nörojen mesane (NB) popülasyonu, AP gelişimi için adaydır. Klinisyenin karmaşık cerrahi müdahale, takip ve tedavi ile uyumlu olmayacağını düşündüğü NB hastalarında ÜK’nin AP’in akut ve uzun süreli yönetimi açısından faydalı olabileceğine inanıyoruz.

References

  • REFERENCES
  • 1-Kitano H, Hieda K, Kitagawa H, Nakaoka Y, Koba Y, Ota K et al. Case Report: Emphysematous Pyelonephritis With a Congenital Giant Ureterocele. Front Pediatr. 2021;9:775468.
  • 2-Kelly HA, MacCallum WG. Pneumaturia. JAMA. (1898) XXXI:375–81.
  • 3- Pode D, Perlberg S, Fine H. Emphysematous renal and perirenal infection in nondiabetic patient. Urology. 1985;26(3):313-5.
  • 4- Arsene C, Saste A, Arul S, Mestrovich J, Kammo R, Elbashir M et al. A case series of emphysematous pyelonephritis. Case Rep Med. 2014;2014:587926.
  • 5- Lu YC, Chiang BJ, Pong YH, Chen CH, Pu YS, Hsueh PR et al. Emphysematous pyelonephritis: clinical characteristics and prognostic factors. Int J Urol. 2014 Mar;21:277-82.
  • 6- Jiya FB, Ibitoye PK, Jiya NM, Amodu-Sanni M, Mohammed Y, Aquib DM et al. Emphysematous pyelonephritis in an infant from Sokoto, north-western Nigeria. Afr J Lab Med. 2021;10:1181.
  • 7- Roberts JA. Management of pyelonephritis and upper urinary tract infections. Urol Clin North Am. 1999;26(4):753-63.
  • 8- Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160(6):797-805.
  • 9- Mohsin N, Budruddin M, Lala S, Al-Taie S. Emphysematous pyelonephritis: a case report series of four patients with review of literature. Ren Fail. 2009;31(7):597-601.
  • 10- Turney JH. Renal conservation for gas-forming infections. Lancet. 2000;355(9206):770-1.
There are 11 citations in total.

Details

Primary Language English
Subjects Surgery
Journal Section CASE REPORTS
Authors

Günay Ekberli 0000-0002-0021-5998

Sevgin Taner 0000-0003-1578-789X

Nevzat Şener 0000-0003-3974-187X

Early Pub Date May 3, 2023
Publication Date May 29, 2023
Submission Date November 3, 2022
Published in Issue Year 2023 Volume: 17 Issue: 3

Cite

Vancouver Ekberli G, Taner S, Şener N. Unusual surgical treatment option for an uncommon disease: Ureterocutaneostomy in an emphysemateous pyelonephritis patient. Türkiye Çocuk Hast Derg. 2023;17(3):253-5.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.